Cargando…
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines
Inactivated viral vaccines have long been used in humans for diseases of global health threat and are now among the vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key consider...
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834840/ https://www.ncbi.nlm.nih.gov/pubmed/32747214 http://dx.doi.org/10.1016/j.vaccine.2020.07.028 |
| _version_ | 1783642375912947712 |
|---|---|
| author | Kochhar, Sonali Excler, Jean-Louis Kim, Denny Robertson, James S. Fast, Patricia E. Condit, Richard C. Drew, Stephen Wood, David Gurwith, Marc Klug, Bettina Whelan, Mike Khuri-Bulos, Najwa Mallett Moore, Tamala Smith, Emily R. Chen, Robert T. |
| author_facet | Kochhar, Sonali Excler, Jean-Louis Kim, Denny Robertson, James S. Fast, Patricia E. Condit, Richard C. Drew, Stephen Wood, David Gurwith, Marc Klug, Bettina Whelan, Mike Khuri-Bulos, Najwa Mallett Moore, Tamala Smith, Emily R. Chen, Robert T. |
| author_sort | Kochhar, Sonali |
| collection | PubMed |
| description | Inactivated viral vaccines have long been used in humans for diseases of global health threat and are now among the vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of inactivated viral vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of the vaccine platform. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed inactivated viral vaccines. |
| format | Online Article Text |
| id | pubmed-7834840 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78348402021-01-26 The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines Kochhar, Sonali Excler, Jean-Louis Kim, Denny Robertson, James S. Fast, Patricia E. Condit, Richard C. Drew, Stephen Wood, David Gurwith, Marc Klug, Bettina Whelan, Mike Khuri-Bulos, Najwa Mallett Moore, Tamala Smith, Emily R. Chen, Robert T. Vaccine Article Inactivated viral vaccines have long been used in humans for diseases of global health threat and are now among the vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of inactivated viral vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of the vaccine platform. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed inactivated viral vaccines. The Author(s). Published by Elsevier Ltd. 2020-09-03 2020-07-31 /pmc/articles/PMC7834840/ /pubmed/32747214 http://dx.doi.org/10.1016/j.vaccine.2020.07.028 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Kochhar, Sonali Excler, Jean-Louis Kim, Denny Robertson, James S. Fast, Patricia E. Condit, Richard C. Drew, Stephen Wood, David Gurwith, Marc Klug, Bettina Whelan, Mike Khuri-Bulos, Najwa Mallett Moore, Tamala Smith, Emily R. Chen, Robert T. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title_full | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title_fullStr | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title_full_unstemmed | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title_short | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| title_sort | brighton collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834840/ https://www.ncbi.nlm.nih.gov/pubmed/32747214 http://dx.doi.org/10.1016/j.vaccine.2020.07.028 |
| work_keys_str_mv | AT kochharsonali thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT exclerjeanlouis thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT kimdenny thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT robertsonjamess thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT fastpatriciae thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT conditrichardc thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT drewstephen thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT wooddavid thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT gurwithmarc thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT klugbettina thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT whelanmike thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT khuribulosnajwa thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT mallettmooretamala thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT smithemilyr thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT chenrobertt thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT thebrightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT kochharsonali brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT exclerjeanlouis brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT kimdenny brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT robertsonjamess brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT fastpatriciae brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT conditrichardc brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT drewstephen brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT wooddavid brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT gurwithmarc brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT klugbettina brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT whelanmike brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT khuribulosnajwa brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT mallettmooretamala brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT smithemilyr brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT chenrobertt brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines AT brightoncollaborationstandardizedtemplateforcollectionofkeyinformationforbenefitriskassessmentofinactivatedviralvaccines |